Your browser doesn't support javascript.
Access to data from clinical trials in the COVID-19 crisis: open, flexible, and time-sensitive.
Ewers, Michael; Ioannidis, John P A; Plesnila, Nikolaus.
  • Ewers M; Institute for Stroke and Dementia Research, University Hospital Munich, Ludwig Maximilian University, Munich, Germany; LMU Open Science Center (OSC), Ludwig Maximilian University, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich. Electronic address: michael.ewers@med.uni-muenchen.de.
  • Ioannidis JPA; Department of Medicine, Department of Epidemiology and Population Health, Department of Biomedical Data Science, Department of Statistics, Meta-Research Innovation Center at Stanford (METRICS), Stanford University, CA, USA. Electronic address: jioannid@stanford.edu.
  • Plesnila N; Institute for Stroke and Dementia Research, University Hospital Munich, Ludwig Maximilian University, Munich, Germany; LMU Open Science Center (OSC), Ludwig Maximilian University, Munich, Germany.
J Clin Epidemiol ; 130: 143-146, 2021 02.
Article in English | MEDLINE | ID: covidwho-1065302

Full text: Available Collection: International databases Database: MEDLINE Main subject: Clinical Trials as Topic / COVID-19 Drug Treatment / Hydroxychloroquine Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: J Clin Epidemiol Journal subject: Epidemiology Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Clinical Trials as Topic / COVID-19 Drug Treatment / Hydroxychloroquine Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: J Clin Epidemiol Journal subject: Epidemiology Year: 2021 Document Type: Article